Bain Capital Life Sciences Investors, LLC Q1 2024 Filing

Filed May 15, 2024

Portfolio Value

$1.2T

Holdings

26

Report Date

Q1 2024

Filing Type

13F-HR

All Holdings (26 positions)

StockValue
NAMSNEWAMSTERDAM PHARMA COMPANY
$247.7B
NUVLNUVALENT INC
$202.5B
DNTHDIANTHUS THERAPEUTICS INC
$89.8B
IRONDISC MEDICINE INC
$82.0B
KYTXKYVERNA THERAPEUTICS INC
$78.6B
PHVSPHARVARIS N V
$76.3B
YB4PSAVARA INC
$72.5B
ANNXANNEXON INC
$62.4B
SLDBSOLID BIOSCIENCES INC
$53.7B
MDGLMADRIGAL PHARMACEUTICALS INC
$52.6B
MERSANA THERAPEUTICS INC
$38.8B
CABACABALETTA BIO INC
$27.6B
ASNSUSDX4 PHARMACEUTICALS INC
$23.5B
TNGXTANGO THERAPEUTICS INC
$23.0B
ARQTARCUTIS BIOTHERAPEUTICS INC
$19.9B
NRIXNURIX THERAPEUTICS INC
$16.6B
SYRSSYROS PHARMACEUTICALS INC
$14.7B
MRNS*MARINUS PHARMACEUTICALS INC
$12.6B
AVIRATEA PHARMACEUTICALS INC
$10.0B
CCCCC4 THERAPEUTICS INC
$9.3B
RPIDRAPID MICRO BIOSYSTEMS INC
$8.2B
IVVDINVIVYD INC
$8.0B
NAUTNAUTILUS BIOTECHNOLOGY INC
$5.9B
ACRSACLARIS THERAPEUTICS INC
$3.7B
XLOXILIO THERAPEUTICS INC
$3.0B
NAMSNEWAMSTERDAM PHARMA COMPANY
$1.1B